GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Compute Health Acquisition Corp (NYSE:CPUH) » Definitions » ROE %

Compute Health Acquisition (Compute Health Acquisition) ROE % : -66.93% (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Compute Health Acquisition ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Compute Health Acquisition's annualized net income for the quarter that ended in Mar. 2023 was $-53.20 Mil. Compute Health Acquisition's average Total Stockholders Equity over the quarter that ended in Mar. 2023 was $79.48 Mil. Therefore, Compute Health Acquisition's annualized ROE % for the quarter that ended in Mar. 2023 was -66.93%.

The historical rank and industry rank for Compute Health Acquisition's ROE % or its related term are showing as below:

CPUH' s ROE % Range Over the Past 10 Years
Min: 1.2   Med: 4.37   Max: 7.3
Current: 1.2

During the past 3 years, Compute Health Acquisition's highest ROE % was 7.30%. The lowest was 1.20%. And the median was 4.37%.

CPUH's ROE % is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.745 vs CPUH: 1.20

Compute Health Acquisition ROE % Historical Data

The historical data trend for Compute Health Acquisition's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compute Health Acquisition ROE % Chart

Compute Health Acquisition Annual Data
Trend Dec20 Dec21 Dec22
ROE %
- 1.44 7.30

Compute Health Acquisition Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.33 4.76 4.09 1.20 -66.93

Competitive Comparison of Compute Health Acquisition's ROE %

For the Shell Companies subindustry, Compute Health Acquisition's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Compute Health Acquisition's ROE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Compute Health Acquisition's ROE % distribution charts can be found below:

* The bar in red indicates where Compute Health Acquisition's ROE % falls into.



Compute Health Acquisition ROE % Calculation

Compute Health Acquisition's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=32.371/( (800.984+86.133)/ 2 )
=32.371/443.5585
=7.30 %

Compute Health Acquisition's annualized ROE % for the quarter that ended in Mar. 2023 is calculated as

ROE %=Net Income (Q: Mar. 2023 )/( (Total Stockholders Equity (Q: Dec. 2022 )+Total Stockholders Equity (Q: Mar. 2023 ))/ count )
=-53.196/( (86.133+72.834)/ 2 )
=-53.196/79.4835
=-66.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2023) net income data. ROE % is displayed in the 30-year financial page.


Compute Health Acquisition  (NYSE:CPUH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2023 )
=Net Income/Total Stockholders Equity
=-53.196/79.4835
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-53.196 / 0)*(0 / 96.1495)*(96.1495 / 79.4835)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.2097
=ROA %*Equity Multiplier
=N/A %*1.2097
=-66.93 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2023 )
=Net Income/Total Stockholders Equity
=-53.196/79.4835
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-53.196 / -52.388) * (-52.388 / -14.248) * (-14.248 / 0) * (0 / 96.1495) * (96.1495 / 79.4835)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0154 * 3.6769 * N/A % * 0 * 1.2097
=-66.93 %

Note: The net income data used here is four times the quarterly (Mar. 2023) net income data. The Revenue data used here is four times the quarterly (Mar. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Compute Health Acquisition ROE % Related Terms

Thank you for viewing the detailed overview of Compute Health Acquisition's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Compute Health Acquisition (Compute Health Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
1105 North Market Street, 4th Floor, Wilmington, DE, USA, 19890
Compute Health Acquisition Corp is a blank check company.
Executives
Omar Ishrak director, 10 percent owner, officer: Chairman 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Gwendolyn A Watanabe director C/O SARATOGA VENTURES, 210 ALMENDRA AVENUE, LOS GATOS CA 95030
Joshua A Fink director, 10 percent owner, officer: Co-CEO, CFO 540 MADISON AVENUE, 18TH FLOOR, NEW YORK NY 10022
Michael Harsh director 3600 GREEN COURT, SUITE 350, ANN ARBOR MI 48105
Compute Health Sponsor Llc director, 10 percent owner 1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801
Hani Barhoush director 1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801
Jean Nehme director, 10 percent owner, officer: Co-CEO 1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801
Osama Alswailem director 1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801

Compute Health Acquisition (Compute Health Acquisition) Headlines

From GuruFocus

Top 5 3rd Quarter Trades of PUBLIC INVESTMENT FUND

By GuruFocus Research GuruFocus Editor 11-15-2022